WILLIAM ANDREW CLARK, PHD, RD
Dietitian and Nutritionist at University Pkwy, Johnson City, TN

License number
Tennessee LDN2487
Category
Dietitian and Nutritionist
Type
Dietitian, Registered
Address
Address
807 University Pkwy, Johnson City, TN 37614
Phone
(423) 439-4071
(423) 439-4060 (Fax)

Professional information

William A Clark Photo 1

Dr. William A Clark, Johnson City TN - PHD

Specialties:
Dietetics
Address:
807 University Pkwy SUITE 70403, Johnson City 37614
(423) 439-4071 (Phone), (423) 439-4060 (Fax)
Languages:
English


William Andrew Clark Photo 2

William Andrew Clark, Johnson City TN

Specialties:
Dietitian
Address:
807 University Pkwy, Johnson City, TN 37614


William Clark Photo 3

Alpha-Tocopherol Treatment For Cystic Fibrosis

US Patent:
2005007, Apr 7, 2005
Filed:
Sep 20, 2004
Appl. No.:
10/945008
Inventors:
Andreas Papas - Kingsport TN, US
Konstantinos Papas - Jonesborough TN, US
Warren Hopkins - Kingsport TN, US
William Clark - Johnson City TN, US
International Classification:
A61K031/59, A61K031/355, A61K038/43, A61K031/12, A61K031/015
US Classification:
424094100, 514458000, 514167000, 514690000, 514763000
Abstract:
Disclosed herein is an aqueous emulsion of alpha-tocopherol and preferably other forms of vitamin E, coenzyme Q10, beta-carotene, vitamin D, and vitamin K useful for treating complications of cystic fibrosis. The aqueous emulsion improves malabsorption and immunity against infection, and reduces oxidative stress and respiratory complications in cystic fibrosis.


William Clark Photo 4

Coenzyme Q10 Treatment For Cystic Fibrosis

US Patent:
2005007, Apr 7, 2005
Filed:
Sep 20, 2004
Appl. No.:
10/945006
Inventors:
Andreas Papas - Kingsport TN, US
Konstantinos Papas - Jonesborough TN, US
Warren Hopkins - Kinsport TN, US
William Clark - Johnson City TN, US
International Classification:
A61K038/43, A61K031/59, A61K031/015, A61K031/355
US Classification:
424094100, 514167000, 514690000, 514763000, 514458000
Abstract:
Disclosed herein is an aqueous emulsion of coenzyme Q10 and preferably vitamin E, beta-carotene, vitamin D, and vitamin K useful for treating complications of cystic fibrosis. The aqueous emulsion improves malabsorption and immunity against infection, and reduces oxidative stress and respiratory complications in cystic fibrosis.


William Clark Photo 5

Gamma-Tocopherol Treatment For Cystic Fibrosis

US Patent:
2005007, Apr 7, 2005
Filed:
Sep 20, 2004
Appl. No.:
10/945009
Inventors:
Andreas Papas - Kingsport TN, US
Konstantinos Papas - Jonesborough TN, US
Warren Hopkins - Kingsport TN, US
William Clark - Johnson City TN, US
International Classification:
A61K038/43, A61K031/355, A61K031/12, A61K031/015
US Classification:
424094100, 514167000, 514690000, 514763000, 514458000
Abstract:
Disclosed herein is an aqueous emulsion of gamma-tocopherol and preferably other forms of vitamin E, coenzyme Q10, beta-carotene, vitamin D, and vitamin K useful for treating complications of cystic fibrosis. The aqueous emulsion improves malabsorption and immunity against infection, and reduces oxidative stress and respiratory complications in cystic fibrosis.


William Clark Photo 6

Aqueous Emulsions Of Lipophile Solubilized With Vitamin E Tpgs And Linoleic Acid

US Patent:
7790190, Sep 7, 2010
Filed:
Mar 20, 2004
Appl. No.:
10/805122
Inventors:
Andreas M. Papas - Kingsport TN, US
Konstantinos A. Papas - Jonesborough TN, US
Howard K. Hobbs - Kingsport TN, US
Warren Hopkins - Kingsport TN, US
William A. Clark - Johnson City TN, US
Assignee:
Yasoo Health, Inc. - Johnson City TN
International Classification:
A61K 9/00
US Classification:
424400
Abstract:
Disclosed herein is an aqueous emulsion. The lipid phase of the emulsion includes a blend of a therapeutically effective concentration of a lipophile, a concentration of Vitamin E TPGS, and a concentration of linoleic acid. The presence of linoleic acid increases the solubilizing affect of Vitamin E TPGS on the lipophile and thus reduces the amount of Vitamin E TPGS that would otherwise be required in the aqueous emulsion.